Compare PLRX & NBRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PLRX | NBRG |
|---|---|---|
| Founded | 2015 | 2021 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 74.9M | 74.5M |
| IPO Year | 2020 | 2026 |
| Metric | PLRX | NBRG |
|---|---|---|
| Price | $1.15 | $9.96 |
| Analyst Decision | Hold | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $2.67 | N/A |
| AVG Volume (30 Days) | ★ 526.9K | 3.5K |
| Earning Date | 05-06-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.97 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.09 | $9.59 |
| 52 Week High | $1.95 | $9.97 |
| Indicator | PLRX | NBRG |
|---|---|---|
| Relative Strength Index (RSI) | 38.90 | 67.15 |
| Support Level | $1.14 | $9.90 |
| Resistance Level | $1.37 | $9.97 |
| Average True Range (ATR) | 0.06 | 0.01 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 6.90 | 88.50 |
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.
Newbridge Acquisition Ltd is a blank check company.